Expired Canadian patentCanada
Genetically engineered yeast strains
CA 2229328 C · Owner: Aventis Pharma S.A. · Inventors: Delorme, Frederic; Perret, Alain; Pompon, Denis
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Yeast strains expressing human genes coding for enzymes regulating cytochrome P450 expression a method for making same and applications thereof are described.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 13, 1996 and granted March 20, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 13, 2016.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 13, 2018.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledSeptember 13, 1996
GrantedMarch 20, 2012
Term endedSeptember 13, 2016
Patent numberCA 2229328 C
Classification (IPC)C12N1/19 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.